跳至主要内容
临床试验/IRCT20230717058813N1
IRCT20230717058813N1尚未招募3 期

Comparing the effects of three therapeutic regimens of oral prednisolone, intravenous methylprednisolone, and oral prednisolone plus recombinant human thrombopoietin on platelet increase in patients with primary immune thrombocytopenic purpura: a clinical trial study.

Shahid Beheshti University of Medical Sciences0 个研究点目标入组 75 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
尚未招募
入组人数
75

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 60 years(—)
性别
All

入选标准

  • age of 18-60 years,
  • having a normal spleen size
  • suffering from Immune thrombocytopenia (ITP)

排除标准

  • history of chronic kidney diseases
  • history of diabetes
  • pregnant women or pregnancy during study
  • history of secondary Immune thrombocytopenia (ITP) such as (Antiphospholipid syndrome, Myelodysplastic syndromes and vasculitis)
  • patients under treatment with any drugs within 3-month before participating in study

研究者

相似试验